Serum methylarginines and incident depression in a cohort of older adults

Journal of Affective Disorders

Volumn 151, Issue 2, 2013, Pages 493-499

  Mcevoy, Mark A ^a   Schofield, Peter ^b   Smith, Wayne ^c   Agho, Kingsley ^d   Mangoni, Arduino A ^j   Soiza, Roy L ^e,f   Peel, Roseanne ^a   Hancock, Stephen ^a   Kelly, Brian ^b   Inder, Kerry ^b,g   Carru, Ciriaco ^h   Zinellu, Angelo ^h   Attia, John ^a,i  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c New South Wales Government   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f WOODEND HOSPITAL   (United Kingdom)

^g Hunter Institute of Mental Health   (Australia)

^h UNIVERSITY OF SASSARI   (Italy)

ⁱ JOHN HUNTER HOSPITAL   (Australia)

^j FLINDERS MEDICAL CENTRE   (Australia)

more..

Author keywords

Cohort study; Depression; Methylarginines

Indexed keywords

6 N,N' DIMETHYLARGININE; ANTIDEPRESSANT AGENT; ARGININE; N(G),N(G) DIMETHYLARGININE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; ASTHMA; AUSTRALIA; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL STUDY; COHORT ANALYSIS; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN METHYLATION; QUESTIONNAIRE; SELF REPORT; SEX RATIO; TANDEM MASS SPECTROMETRY;

COHORT STUDY; DEPRESSION; METHYLARGININES;

AGED; AGED, 80 AND OVER; ARGININE; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW SOUTH WALES; NITRIC OXIDE SYNTHASE;

EID: 84885472892     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.06.033     Document Type: Article

References (39)

1. M.T. Bedford, and S. Richard Arginine methylation: an emerging regulator of protein function Molecular Cell 18 2005 263 272
2. D.S. Bredt, P.M. Hwang, and S.H. Snyder Localization of nitric oxide synthase indicating a neural role for nitric oxide Nature 347 1990 768 770
3. E.J. Calabrese, K.A. Bachmann, A.J. Bailer, P.M. Bolger, J. Borak, L. Cai, N. Cedergreen, M.G. Cherian, C.C. Chiueh, and T.W. Clarkson Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework Toxicology and Applied Pharmacology 222 2007 122 128
4. R.O. Cannon Role of nitric oxide in cardiovascular disease: focus on the endothelium Clinical Chemistry 44 1998 1809 1819
5. B. Caplin, and J. Leiper Endogenous nitric oxide synthase inhibitors in the biology of disease markers, mediators, and regulators? Arteriosclerosis, Thrombosis, and Vascular Biology 32 2012 1343 1353
6. A.J. Cardounel, Y. Xia, and J.L. Zweier Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase Journal of Biological Chemistry 280 2005 7540 7549
7. C.M. Celano, and J.C. Huffman Depression and cardiac disease: a review Cardiology in Review 19 2011 130 142
8. W. Chrapko, P. Jurasz, M.W. Radomski, S.L. Archer, S.C. Newman, G. Baker, N. Lara, and J.M. Le Mellédo Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients Neuropsychopharmacology 31 2005 1286 1293
9. W.E. Chrapko, P. Jurasz, M.W. Radomski, N. Lara, S.L. Archer, and J.M. Le Mellédo Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder Biological Psychiatry 56 2004 129 134
10. T. Dawson, and S.H. Snyder Gases as biological messengers: nitric oxide and carbon monoxide in the brain The Journal of Neuroscience 14 1994 5147 5159
11. V.L. Dawson, and T.M. Dawson Nitric oxide neurotoxicity Journal of Chemical Neuroanatomy 10 1996 179
12. A. Dhir, and S.K. Kulkarni Nitric oxide and major depression Nitric Oxide 24 2011 125 131
13. D. Fliser Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule European Journal of Clinical Investigation 35 2005 71 79
14. F. Guix, I. Uribesalgo, M. Coma, and F. Munoz The physiology and pathophysiology of nitric oxide in the brain Progress in Neurobiology 76 2005 126 152
15. A. Ikenouchi-Sugita, R. Yoshimura, H. Hori, W. Umene-Nakano, N. Ueda, and J. Nakamura Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 2009 1451 1453
16. Y.K. Kim, J.W. Paik, S.W. Lee, D. Yoon, C. Han, and B.H. Lee Increased plasma nitric oxide level associated with suicide attempt in depressive patients Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 2006 1091 1096
17. J. Kishimoto, T. Tsuchiya, P.C. Emson, and Y. Nakayama Immobilisation-induced stress activates neuronal nitric oxide synthase (nNOS) mRNA and protein in hypothalamic-pituitary-adrenal axis in rats Brain Research 720 1996 159 171
18. I. Kostoglou-Athanassiou, A. Costa, P. Navarra, G. Nappi, M.L. Forsling, and A.B. Grossman Endotoxin stimulates an endogenous pathway regulating corticotropin-releasing hormone and vasopressin release involving the generation of nitric oxide and carbon monoxide Journal of Neuroimmunology 86 1998 104 109
19. B.H. Lee, S.W. Lee, D. Yoon, H.J. Lee, J.C. Yang, S.H. Shim, D.H. Kim, S.H. Ryu, C. Han, and Y.K. Kim Increased plasma nitric oxide metabolites in suicide attempters Neuropsychobiology 53 2006 127 132
20. S. Lee, G. Barbanel, and C. Rivier Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts Brain Research 705 1995 136 148
21. C. Mancuso, P. Navarra, and P. Preziosi Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary- adrenal axis Journal of Neurochemistry 113 2010 563 575
22. A.A. Mangoni The emerging role of symmetric dimethylarginine in vascular disease Advances in Clinical Chemistry 48 2009 73 94
23. M. Mcevoy, W. Smith, C. D'este, J. Duke, R. Peel, P. Schofield, R. Scott, J. Byles, D. Henry, B. Ewald, S. Hancock, D. Smith, and J. Attia Cohort profile: the Hunter Community Study International Journal of Epidemiology 39 2010 1452 1463
24. P. Pacher, J.S. Beckman, and L. Liaudet Nitric oxide and peroxynitrite in health and disease Physiological Reviews 87 2007 315 424
25. V.L.M. Pinto, T. Brunini, M.R. Ferraz, A. Okinga, and A.C. Mendes-Ribeiro Depression and cardiovascular disease: role of nitric oxide Cardiovascular and Hematological Agents in Medicinal Chemistry 6 2008 142 149
26. L.S. Radloff The CES-D scale a self-report depression scale for research in the general population Applied Psychological Measurement 1 1977 385 401
27. R.N. Rodionov, D.J. Murry, S.F. Vaulman, J.W. Stevens, and S.R. Lentz Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production Journal of Biological Chemistry 285 2010 5385 5391
28. F. Sanchez, M. Moreno, P. Vacas, J. Carretero, and R. Vazquez Swim stress enhances the NADPH-diaphorase histochemical staining in the paraventricular nucleus of the hypothalamus Brain Research 828 1999 159 162
29. G. Segarra, P. Medina, R. Ballester, P. Lluch, M. Aldasoro, J. Vila, and S. Lluch Effects of some guanidino compounds on human cerebral arteries Stroke 30 1999 2206 2211
30. G. Segarra, P. Medina, J.M. Vila, P. Chuan, C. Domenech, B. Torondel, and S. Lluch Inhibition of nitric oxide activity by arginine analogs in human renal arteries American Journal of Hypertension 14 2001 1142 1148
31. M.L. Selley Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression Journal of Affective Disorders 80 2004 249 256
32. D. Souery, G.I. Papakostas, and M.H. Trivedi Treatment-resistant depression Journal of Clinical Psychiatry 67 2006 16 22
33. N. Srivastava, M.K. Barthwal, P.K. Dalal, A.K. Agarwal, D. Nag, P.K. Seth, R.C. Srimal, and M. Dikshit A study on nitric oxide, β-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression Journal of Affective Disorders 72 2002 45 52
34. E. Suzuki, G. Yagi, T. Nakaki, S. Kanba, and M. Asai Elevated plasma nitrate levels in depressive states Journal of Affective Disorders 63 2001 221 224
35. C.T.L. Tran, M.F. Fox, P. Vallance, and J.M. Leiper Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins Genomics 68 2000 101 105
36. T. Tsuchiya, J. Kishimoto, J. Koyama, and T. Ozawa Modulatory effect of-NAME, a specific nitric oxide synthase (NOS) inhibitor, on stress-induced changes in plasma adrenocorticotropic hormone (ACTH) and corticosterone levels in rats: physiological significance of stress-induced NOS activation in hypothalamic-pituitary-adrenal axis Brain Research 776 1997 68 74
37. G. Wegener, and V. Volke Nitric oxide synthase inhibitors as antidepressants Pharmaceuticals 3 2010 273 299
38. World Health Organisation, 2012. Depression [Online]. Available from: http://www.who.int/mental-health/management/depression/definition/en/.
39. World Health Organisation The World Health Report Mental Health, New Understanding 2001 2001 World Health Organisation New Hope